日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial

恩西替利韦治疗非住院成人 COVID-19 患者：SCORPIO-HR 3 期随机、双盲、安慰剂对照试验结果

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciaf029
Luetkemeyer, Anne F; Chew, Kara W; Lacey, Stuart; Hughes, Michael D; Harrison, Linda J; Daar, Eric S; Eron, Joseph; Fletcher, Courtney V; Greninger, Alexander L; Hessinger, Diane; Li, Jonathan Z; Mailhot, David; Wohl, David; Chayakulkeeree, Methee; Mendoza, Jose Luis Accini; Elistratova, Polina; Makinde, Oluwaseun; Morgan, Gareth; Portsmouth, Simon; Uehara, Takeki; Smith, Davey; Currier, Judith S
发表日期：2025
文献求助 收藏

Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review

恩西替利韦作为轻中度 COVID-19 的一种新型治疗选择：文献综述

期刊:Therapeutic Advances in Infectious Disease
影响因子:3.4
doi:10.1177/20499361251321724
Mukae, Hiroshi; Yotsuyanagi, Hiroshi; Ohmagari, Norio; Doi, Yohei; Yamato, Masaya; Imamura, Takumi; Sakaguchi, Hiroki; Sanaki, Takao; Sonoyama, Takuhiro; Tsuge, Yuko; Uehara, Takeki
发表日期：2025
文献求助 收藏

Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial

5天口服恩西替利韦治疗轻度至中度COVID-19患者的疗效和安全性：SCORPIO-SR随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.54991
Yotsuyanagi, Hiroshi; Ohmagari, Norio; Doi, Yohei; Yamato, Masaya; Bac, Nguyen Hoang; Cha, Bong Ki; Imamura, Takumi; Sonoyama, Takuhiro; Ichihashi, Genki; Sanaki, Takao; Tsuge, Yuko; Uehara, Takeki; Mukae, Hiroshi
发表日期：2024
文献求助 收藏

Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19

恩西替利韦在降低新冠肺炎高危门诊患者严重不良结局方面的真实世界疗效

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-01010-4
Takazono, Takahiro; Fujita, Satoki; Komeda, Takuji; Miyazawa, Shogo; Yoshida, Yuki; Kitanishi, Yoshitake; Kinoshita, Masahiro; Kojima, Satoshi; Shen, Huilian; Uehara, Takeki; Hosogaya, Naoki; Iwanaga, Naoki; Mukae, Hiroshi
肺炎
新冠
微生物学
发表日期：2024
文献求助 收藏

Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19"

致编辑的信，关于对“致编辑的信：‘恩西替利韦在降低COVID-19高危门诊患者严重后果方面的真实世界疗效’”的回应

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-01054-6
Takazono, Takahiro; Fujita, Satoki; Komeda, Takuji; Miyazawa, Shogo; Yoshida, Yuki; Kitanishi, Yoshitake; Kinoshita, Masahiro; Kojima, Satoshi; Shen, Huilian; Uehara, Takeki; Hosogaya, Naoki; Iwanaga, Naoki; Mukae, Hiroshi
发表日期：2024
文献求助 收藏

Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial

恩西替利韦治疗无症状或轻症 COVID-19 的疗效和安全性：一项多中心、随机、2b/3 期临床试验的探索性分析

期刊:Influenza and Other Respiratory Viruses
影响因子:4.2
doi:10.1111/irv.13338
Ohmagari, Norio; Yotsuyanagi, Hiroshi; Doi, Yohei; Yamato, Masaya; Imamura, Takumi; Sakaguchi, Hiroki; Yamanaka, Hideki; Imaoka, Ryosuke; Fukushi, Akimasa; Ichihashi, Genki; Sanaki, Takao; Tsuge, Yuko; Uehara, Takeki; Mukae, Hiroshi
发表日期：2024
文献求助 收藏

Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study

恩西替利韦治疗轻度至中度冠状病毒病2019患者的疗效和安全性：一项随机、安慰剂对照的2/3期研究的2b期部分

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciac933
Mukae, Hiroshi; Yotsuyanagi, Hiroshi; Ohmagari, Norio; Doi, Yohei; Sakaguchi, Hiroki; Sonoyama, Takuhiro; Ichihashi, Genki; Sanaki, Takao; Baba, Keiko; Tsuge, Yuko; Uehara, Takeki
微生物学
发表日期：2023
文献求助 收藏

Investigating the transmission of baloxavir-resistant influenza viruses from treated index patients to untreated household contacts in the BLOCKSTONE study

在 BLOCKSTONE 研究中，调查了巴洛沙韦耐药流感病毒从接受治疗的指标患者向未接受治疗的家庭接触者传播的情况。

期刊:Influenza and Other Respiratory Viruses
影响因子:4.2
doi:10.1111/irv.13079
Harding, Joanne; Bernasconi, Corrado; Williams, Sarah; Wildum, Steffen; Kinoshita, Masahiro; Uehara, Takeki; Hurt, Aeron C
微生物学
流感
发表日期：2023
文献求助 收藏

Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan

巴洛沙韦在流感病毒感染的儿科患者中的安全性及临床和病毒学疗效（按年龄组划分）：两项在日本开展的儿科研究的基于年龄的汇总分析

期刊:BMC Pediatrics
影响因子:2
doi:10.1186/s12887-023-03841-5
Hirotsu, Nobuo; Sakaguchi, Hiroki; Fukao, Keita; Kojima, Satoshi; Piedra, Pedro A; Tsuchiya, Kenji; Uehara, Takeki
炎症/感染
流感
微生物学
发表日期：2023
文献求助 收藏

A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)

S-217622 在 SARS-CoV-2 感染者中的 2/3 期研究（3 期部分）

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000033024
Yotsuyanagi, Hiroshi; Ohmagari, Norio; Doi, Yohei; Imamura, Takumi; Sonoyama, Takuhiro; Ichihashi, Genki; Sanaki, Takao; Tsuge, Yuko; Uehara, Takeki; Mukae, Hiroshi
炎症/感染
SARS-CoV-2
发表日期：2023
文献求助 收藏